Additionally, OPN is involved in pathophysiological processes, such as malignancy, insulin resistance, T2DM, atherosclerosis, end-stage kidney failure, obesity-induced inflammation, and osteoporosis [42,43]. This evidence concerns the gene SPP1 and obesity due to melanocortin 4 receptor deficiency.